{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:44:15Z","timestamp":1791474255977,"version":"4.3.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100014605","name":"Sage Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s40273-021-01021-w","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T22:12:35Z","timestamp":1619561555000},"page":"691-706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1193-4258","authenticated-orcid":false,"given":"Alix","family":"Arnaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellison","family":"Suthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita M.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi J.","family":"Ravindranath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"1021_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). 5th ed. Washington DC: 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"Suppl. 10","key":"1021_CR2","first-page":"9","volume":"167","author":"A Gelenberg","year":"2010","unstructured":"Gelenberg A, Freeman M, Markowitz J, Rosenbaum J, Thase M, Trivedi M, et al. American Psychiatric Association practice guidelines for the treatment of patients with major depressive disorder. Am J Psychiatry. 2010;167(Suppl. 10):9\u2013118.","journal-title":"Am J Psychiatry."},{"issue":"8","key":"1021_CR3","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1001\/jamapsychiatry.2019.0633","volume":"76","author":"JM Hockenberry","year":"2019","unstructured":"Hockenberry JM, Joski P, Yarbrough C, Druss BG. Trends in treatment and spending for patients receiving outpatient treatment of depression in the United States, 1998\u20132015. JAMA Psychiat. 2019;76(8):810\u20137.","journal-title":"JAMA Psychiat"},{"key":"1021_CR4","unstructured":"12-month prevalence of DSM-IV\/WMH-CIDI disorders by sex and cohort (n=9,282); updated data as of July 19, 2007. 2020. https:\/\/www.hcp.med.harvard.edu\/ncs\/ftpdir\/NCS-R_12-month_Prevalence_Estimates.pdf. Accessed 4 May 2020."},{"key":"1021_CR5","unstructured":"US Census Bureau Population Division. Annual Estimates of the Resident Population by Single Year of Age and Sex for the United States: April 1, 2010 to July 1, 2017. 2018. https:\/\/factfinder.census.gov\/faces\/tableservices\/jsf\/pages\/productview.xhtml?src=bkmk."},{"issue":"4","key":"1021_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1176\/appi.focus.16407","volume":"16","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Focus. 2018;16(4):420\u20139.","journal-title":"Focus"},{"issue":"11","key":"1021_CR7","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. Am J Psychiatry. 2006;163(11):1905\u201317.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1021_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28\u201340.","journal-title":"Am J Psychiatry"},{"issue":"11","key":"1021_CR9","doi-asserted-by":"publisher","first-page":"e1480","DOI":"10.4088\/jcp.13097tx1c","volume":"76","author":"AA Nierenberg","year":"2015","unstructured":"Nierenberg AA. Residual symptoms in depression: prevalence and impact. J Clin Psychiatry. 2015;76(11):e1480. https:\/\/doi.org\/10.4088\/jcp.13097tx1c.","journal-title":"J Clin Psychiatry."},{"issue":"1","key":"1021_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1017\/s0033291709006011","volume":"40","author":"AA Nierenberg","year":"2010","unstructured":"Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR, et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med. 2010;40(1):41\u201350. https:\/\/doi.org\/10.1017\/s0033291709006011.","journal-title":"Psychol Med."},{"issue":"1","key":"1021_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12888-017-1385-0","volume":"17","author":"G Gauthier","year":"2017","unstructured":"Gauthier G, Gu\u00e9rin A, Zhdanava M, Jacobson W, Nomikos G, Merikle E, et al. Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis. BMC Psychiatry. 2017;17(1):222. https:\/\/doi.org\/10.1186\/s12888-017-1385-0.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"1021_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/ijnp\/pyx081","volume":"21","author":"OJ Oluboka","year":"2018","unstructured":"Oluboka OJ, Katzman MA, Habert J, McIntosh D, MacQueen GM, Milev RV, et al. Functional recovery in major depressive disorder: providing early optimal treatment for the individual patient. Int J Neuropsychopharmacol. 2018;21(2):128\u201344. https:\/\/doi.org\/10.1093\/ijnp\/pyx081.","journal-title":"Int J Neuropsychopharmacol."},{"issue":"2","key":"1021_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1176\/appi.ajp.157.2.229","volume":"157","author":"DA Solomon","year":"2000","unstructured":"Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry. 2000;157(2):229\u201333.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1021_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jad.2012.07.008","volume":"145","author":"JD Bukh","year":"2013","unstructured":"Bukh JD, Bock C, Vinberg M, Kessing LV. The effect of prolonged duration of untreated depression on antidepressant treatment outcome. J Affect Disord. 2013;145(1):42\u20138.","journal-title":"J Affect Disord"},{"issue":"5","key":"1021_CR15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/mp.2012.33","volume":"18","author":"S Moylan","year":"2013","unstructured":"Moylan S, Maes M, Wray NR, Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry. 2013;18(5):595\u2013606. https:\/\/doi.org\/10.1038\/mp.2012.33.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"1021_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/2040622316639769","volume":"7","author":"WW IsHak","year":"2016","unstructured":"IsHak WW, James DM, Mirocha J, Youssef H, Tobia G, Pi S, et al. Patient-reported functioning in major depressive disorder. Ther Adv Chronic Dis. 2016;7(3):160\u20139. https:\/\/doi.org\/10.1177\/2040622316639769.","journal-title":"Ther Adv Chronic Dis."},{"key":"1021_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4088\/PCC.15r01926","volume":"18","author":"J Habert","year":"2016","unstructured":"Habert J, Katzman MA, Oluboka OJ, McIntyre RS, McIntosh D, MacQueen GM, et al. Functional recovery in major depressive disorder: focus on early optimized treatment. Prim Care Companion CNS Disord. 2016;18:5. https:\/\/doi.org\/10.4088\/PCC.15r01926.","journal-title":"Prim Care Companion CNS Disord."},{"issue":"1","key":"1021_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psc.2011.11.005","volume":"35","author":"RC Kessler","year":"2012","unstructured":"Kessler RC. The costs of depression. Psychiatr Clin N Am. 2012;35(1):1\u201314. https:\/\/doi.org\/10.1016\/j.psc.2011.11.005.","journal-title":"Psychiatr Clin N Am."},{"issue":"4","key":"1021_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1017\/S0033291710001212","volume":"41","author":"J Alonso","year":"2011","unstructured":"Alonso J, Vilagut G, Chatterji S, Heeringa S, Schoenbaum M, \u00dcst\u00fcn TB, et al. Including information about co-morbidity in estimates of disease burden: results from the World Health Organization World Mental Health Surveys. Psychol Med. 2011;41(4):873\u201386.","journal-title":"Psychol Med"},{"issue":"6","key":"1021_CR20","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","volume":"24","author":"RJ Anderson","year":"2001","unstructured":"Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069\u201378.","journal-title":"Diabetes Care"},{"issue":"6","key":"1021_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1600-0447.2005.00513.x","volume":"111","author":"M Buist-Bouwman","year":"2005","unstructured":"Buist-Bouwman M, de Graaf R, Vollebergh W, Ormel J. Comorbidity of physical and mental disorders and the effect on work-loss days. Acta Psychiatr Scand. 2005;111(6):436\u201343.","journal-title":"Acta Psychiatr Scand"},{"key":"1021_CR22","first-page":"1","volume":"2","author":"DP Chapman","year":"2005","unstructured":"Chapman DP, Perry GS, Strine TW. Peer reviewed: the vital link between chronic disease and depressive disorders. Prevent Chronic Dis. 2005;2:1.","journal-title":"Prevent Chronic Dis."},{"issue":"6","key":"1021_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/jama.1983.03330300035030","volume":"249","author":"LR Derogatis","year":"1983","unstructured":"Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249(6):751\u20137.","journal-title":"JAMA"},{"key":"1021_CR24","volume-title":"Adversity, stress, and psychopathology","year":"1998","unstructured":"Dohrenwend Bruce P, editor. Adversity, stress, and psychopathology. Oxford University Press; 1998."},{"issue":"11","key":"1021_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1136\/jech.56.11.843","volume":"56","author":"D Manuel","year":"2002","unstructured":"Manuel D, Schultz S, Kopec J. Measuring the health burden of chronic disease and injury using health adjusted life expectancy and the Health Utilities Index. J Epidemiol Community Health. 2002;56(11):843\u201350.","journal-title":"J Epidemiol Community Health"},{"issue":"1\u20132","key":"1021_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0304-3959(03)00301-4","volume":"106","author":"LA McWilliams","year":"2003","unstructured":"McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003;106(1\u20132):127\u201333.","journal-title":"Pain"},{"issue":"S1","key":"1021_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/(SICI)1520-6394(1998)8:1+<71::AID-DA11>3.0.CO;2-X","volume":"8","author":"CB Nemeroff","year":"1998","unstructured":"Nemeroff CB, Musselman DL, Evans DL. Depression and cardiac disease. Depress Anxiety. 1998;8(S1):71\u20139.","journal-title":"Depress Anxiety"},{"issue":"12","key":"1021_CR28","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00127-006-0121-8","volume":"41","author":"AN Ortega","year":"2006","unstructured":"Ortega AN, Feldman JM, Canino G, Steinman K, Alegr\u00eda M. Co-occurrence of mental and physical illness in US Latinos. Soc Psychiatry Psychiatr Epidemiol. 2006;41(12):927\u201334.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"11","key":"1021_CR29","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1176\/ajp.146.11.1440","volume":"146","author":"KB Wells","year":"1989","unstructured":"Wells KB, Golding JM, Burnam MA. Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders. Am J Psychiatry. 1989;146(11):1440\u20136.","journal-title":"Am J Psychiatry."},{"issue":"5","key":"1021_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1192\/bjp.bp.112.118307","volume":"202","author":"BS Diniz","year":"2013","unstructured":"Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd. Late-life depression and risk of vascular dementia and Alzheimer\u2019s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329\u201335. https:\/\/doi.org\/10.1192\/bjp.bp.112.118307.","journal-title":"Br J Psychiatry."},{"key":"1021_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pnpbp.2018.05.025","volume":"86","author":"S Wang","year":"2018","unstructured":"Wang S, Mao S, Xiang D, Fang C. Association between depression and the subsequent risk of Parkinson\u2019s disease: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2018;86:186\u201392. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.05.025.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"issue":"7","key":"1021_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/gps.1723","volume":"22","author":"K Van der Kooy","year":"2007","unstructured":"Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry. 2007;22(7):613\u201326. https:\/\/doi.org\/10.1002\/gps.1723.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"12","key":"1021_CR33","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.2337\/dc08-0985","volume":"31","author":"B Mezuk","year":"2008","unstructured":"Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383\u201390. https:\/\/doi.org\/10.2337\/dc08-0985.","journal-title":"Diabetes Care"},{"issue":"2","key":"1021_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.psychres.2009.04.015","volume":"178","author":"L de Wit","year":"2010","unstructured":"de Wit L, Luppino F, van Straten A, Penninx B, Zitman F, Cuijpers P. Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res. 2010;178(2):230\u20135. https:\/\/doi.org\/10.1016\/j.psychres.2009.04.015.","journal-title":"Psychiatry Res."},{"issue":"16","key":"1021_CR35","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1017\/s0033291715001488","volume":"45","author":"NW Andersson","year":"2015","unstructured":"Andersson NW, Gustafsson LN, Okkels N, Taha F, Cole SW, Munk-J\u00f8rgensen P, et al. Depression and the risk of autoimmune disease: a nationally representative, prospective longitudinal study. Psychol Med. 2015;45(16):3559\u201369. https:\/\/doi.org\/10.1017\/s0033291715001488.","journal-title":"Psychol Med."},{"issue":"2","key":"1021_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1017\/s0033291703001041","volume":"34","author":"SL Larson","year":"2004","unstructured":"Larson SL, Clark MR, Eaton WW. Depressive disorder as a long-term antecedent risk factor for incident back pain: a 13-year follow-up study from the Baltimore Epidemiological Catchment Area sample. Psychol Med. 2004;34(2):211\u20139. https:\/\/doi.org\/10.1017\/s0033291703001041.","journal-title":"Psychol Med."},{"issue":"5","key":"1021_CR37","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1192\/bjp.bp.107.038380","volume":"192","author":"A Farmer","year":"2008","unstructured":"Farmer A, Korszun A, Owen MJ, Craddock N, Jones L, Jones I, et al. Medical disorders in people with recurrent depression. Br J Psychiatry. 2008;192(5):351\u20135.","journal-title":"Br J Psychiatry"},{"issue":"5","key":"1021_CR38","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/HJH.0b013e32835080b7","volume":"30","author":"L Meng","year":"2012","unstructured":"Meng L, Chen D, Yang Y, Zheng Y, Hui R. Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies. J Hypertens. 2012;30(5):842\u201351. https:\/\/doi.org\/10.1097\/HJH.0b013e32835080b7.","journal-title":"J Hypertens."},{"issue":"5","key":"1021_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.genhosppsych.2008.05.001","volume":"30","author":"SB Patten","year":"2008","unstructured":"Patten SB, Williams JV, Lavorato DH, Modgill G, Jett\u00e9 N, Eliasziw M. Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen Hosp Psychiatry. 2008;30(5):407\u201313.","journal-title":"Gen Hosp Psychiatry"},{"issue":"10","key":"1021_CR40","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1176\/appi.ps.201100342","volume":"63","author":"JD Prince","year":"2012","unstructured":"Prince JD, Walkup J, Akincigil A, Amin S, Crystal S. Serious mental illness and risk of new HIV\/AIDS diagnoses: an analysis of Medicaid beneficiaries in eight states. Psychiatr Serv. 2012;63(10):1032\u20138.","journal-title":"Psychiatr Serv"},{"issue":"2","key":"1021_CR41","doi-asserted-by":"publisher","first-page":"269","DOI":"10.15288\/jsad.2009.70.269","volume":"70","author":"ND Sintov","year":"2009","unstructured":"Sintov ND, Kendler KS, Walsh D, Patterson DG, Prescott CA. Predictors of illicit substance dependence among individuals with alcohol dependence. J Stud Alcohol Drugs. 2009;70(2):269\u201378. https:\/\/doi.org\/10.15288\/jsad.2009.70.269.","journal-title":"J Stud Alcohol Drugs."},{"issue":"9590","key":"1021_CR42","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s0140-6736(07)61415-9","volume":"370","author":"S Moussavi","year":"2007","unstructured":"Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370(9590):851\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(07)61415-9.","journal-title":"Lancet"},{"key":"1021_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ypmed.2014.03.007","volume":"63","author":"H Fan","year":"2014","unstructured":"Fan H, Yu W, Zhang Q, Cao H, Li J, Wang J, et al. Depression after heart failure and risk of cardiovascular and all-cause mortality: a meta-analysis. Prev Med. 2014;63:36\u201342. https:\/\/doi.org\/10.1016\/j.ypmed.2014.03.007.","journal-title":"Prev Med."},{"issue":"3","key":"1021_CR44","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000296135","volume":"79","author":"J Dirmaier","year":"2010","unstructured":"Dirmaier J, Watzke B, Koch U, Schulz H, Lehnert H, Pieper L, et al. Diabetes in primary care: prospective associations between depression, nonadherence and glycemic control. Psychother Psychosom. 2010;79(3):172\u20138. https:\/\/doi.org\/10.1159\/000296135.","journal-title":"Psychother Psychosom."},{"issue":"1","key":"1021_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/psyg.12035","volume":"14","author":"M Sawa","year":"2014","unstructured":"Sawa M, Chan P, Donnelly M, McKenna M, Osaki Y, Kishimoto T, et al. A case\u2013control study regarding relative factors for behavioural and psychological symptoms of dementia at a Canadian regional long-term extended care facility: a preliminary report. Psychogeriatrics. 2014;14(1):25\u201330. https:\/\/doi.org\/10.1111\/psyg.12035.","journal-title":"Psychogeriatrics"},{"issue":"6","key":"1021_CR46","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11892-014-0491-3","volume":"14","author":"RI Holt","year":"2014","unstructured":"Holt RI, de Groot M, Golden SH. Diabetes and depression. Curr Diab Rep. 2014;14(6):491. https:\/\/doi.org\/10.1007\/s11892-014-0491-3.","journal-title":"Curr Diab Rep."},{"issue":"10","key":"1021_CR47","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11606-011-1704-y","volume":"26","author":"JL Grenard","year":"2011","unstructured":"Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011;26(10):1175\u201382. https:\/\/doi.org\/10.1007\/s11606-011-1704-y.","journal-title":"J Gen Intern Med."},{"issue":"2","key":"1021_CR48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4088\/JCP.14m09298","volume":"76","author":"PE Greenberg","year":"2015","unstructured":"Greenberg PE, Fournier A-A, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76(2):155\u201362.","journal-title":"J Clin Psychiatry."},{"issue":"12","key":"1021_CR49","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1080\/03007995.2019.1652053","volume":"35","author":"RS McIntyre","year":"2019","unstructured":"McIntyre RS, Prieto R, Schepman P, Yeh Y-C, Boucher M, Shelbaya A, et al. Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study. Curr Med Res Opin. 2019;35(12):2169\u201377. https:\/\/doi.org\/10.1080\/03007995.2019.1652053.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"1021_CR50","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2165\/00019053-200927060-00006","volume":"27","author":"HG Birnbaum","year":"2009","unstructured":"Birnbaum HG, Ben-Hamadi R, Greenberg PE, Hsieh M, Tang J, Reygrobellet C. Determinants of direct cost differences among US employees with major depressive disorders using antidepressants. Pharmacoeconomics. 2009;27(6):507\u201317. https:\/\/doi.org\/10.2165\/00019053-200927060-00006.","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"1021_CR51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.eurpsy.2006.04.005","volume":"21","author":"L von Knorring","year":"2006","unstructured":"von Knorring L, \u00c5kerblad A-C, Bengtsson F, Carlsson \u00c5, Ekselius L. Cost of depression: effect of adherence and treatment response. Eur Psychiatry. 2006;21(6):349\u201354.","journal-title":"Eur Psychiatry"},{"key":"1021_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4088\/JCP.17m11725","volume":"79","author":"TB Amos","year":"2018","unstructured":"Amos TB, Tandon N, Lefebvre P, Pilon D, Kamstra RL, Pivneva I, et al. Direct and indirect cost burden and change of employment status in treatment-resistant depression: a matched-cohort study using a US commercial claims database. J Clin Psychiatry. 2018;79:2.","journal-title":"J Clin Psychiatry."},{"issue":"4","key":"1021_CR53","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.clinthera.2012.09.001","volume":"35","author":"N Olchanski","year":"2013","unstructured":"Olchanski N, Myers MM, Halseth M, Cyr PL, Bockstedt L, Goss TF, et al. The economic burden of treatment-resistant depression. Clin Ther. 2013;35(4):512\u201322.","journal-title":"Clin Ther"},{"issue":"7","key":"1021_CR54","doi-asserted-by":"publisher","first-page":"823","DOI":"10.18553\/jmcp.2019.25.7.823","volume":"25","author":"M Sussman","year":"2019","unstructured":"Sussman M, O\u2019Sullivan AK, Shah A, Olfson M, Menzin J. Economic burden of treatment-resistant depression on the U.S. health care system. J Manag Care Spec Pharm. 2019;25(7):823\u201335. https:\/\/doi.org\/10.18553\/jmcp.2019.25.7.823.","journal-title":"J Manag Care Spec Pharm."},{"key":"1021_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1371\/journal.pone.0223255","volume":"14","author":"D Pilon","year":"2019","unstructured":"Pilon D, Joshi K, Sheehan JJ, Zichlin ML, Zuckerman P, Lefebvre P, et al. Burden of treatment-resistant depression in Medicare: a retrospective claims database analysis. PLoS ONE. 2019;14:10.","journal-title":"PLoS ONE"},{"key":"1021_CR56","first-page":"201900398","volume":"2020","author":"A Shrestha","year":"2020","unstructured":"Shrestha A, Roach M, Joshi K, Sheehan JJ, Goutam P, Everson K, et al. Incremental health care burden of treatment-resistant depression among Commercial, Medicaid, and Medicare payers. Psychiatric Serv. 2020;2020:201900398.","journal-title":"Psychiatric Serv."},{"issue":"10","key":"1021_CR57","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1185\/03007995.2010.517716","volume":"26","author":"JI Ivanova","year":"2010","unstructured":"Ivanova JI, Birnbaum HG, Kidolezi Y, Subramanian G, Khan SA, Stensland MD. Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder. Curr Med Res Opin. 2010;26(10):2475\u201384. https:\/\/doi.org\/10.1185\/03007995.2010.517716.","journal-title":"Curr Med Res Opin."},{"key":"1021_CR58","unstructured":"US Department of Veterans Affairs. 2020. https:\/\/www.pbm.va.gov\/nationalformulary.asp. Accessed 17 Apr 2020."},{"key":"1021_CR59","unstructured":"United States Bureau of Labor and Statistics. CPI inflation calculator. 2020. http:\/\/www.bls.gov\/data\/inflation_calculator.htm. Accessed 1 Feb 2020."},{"issue":"10","key":"1021_CR60","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1176\/appi.ajp.2010.09060877","volume":"167","author":"TL Mark","year":"2010","unstructured":"Mark TL, Gibson TM, McGuigan K, Chu BC. The effects of antidepressant step therapy protocols on pharmaceutical and medical utilization and expenditures. Am J Psychiatry. 2010;167(10):1202\u20139. https:\/\/doi.org\/10.1176\/appi.ajp.2010.09060877.","journal-title":"Am J Psychiatry."},{"key":"1021_CR61","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1097\/00005650-200412000-00004","volume":"2004","author":"JM Donohue","year":"2004","unstructured":"Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care. 2004;2004:1176\u201385.","journal-title":"Med Care."},{"issue":"2","key":"1021_CR62","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000112885","volume":"77","author":"R Mojtabai","year":"2008","unstructured":"Mojtabai R. Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychother Psychosom. 2008;77(2):83\u201392.","journal-title":"Psychother Psychosom"},{"key":"1021_CR63","first-page":"18","volume":"2015","author":"K Thorpe","year":"2015","unstructured":"Thorpe K, Hockenberry J. Prescription drugs and the slowdown in health care spending. Health Affairs Blog. 2015;2015:18.","journal-title":"Health Affairs Blog."},{"issue":"6","key":"1021_CR64","first-page":"9","volume":"7","author":"J Ventimiglia","year":"2010","unstructured":"Ventimiglia J, Kalali AH. Generic penetration in the retail antidepressant market. Psychiatry (Edgmont). 2010;7(6):9.","journal-title":"Psychiatry (Edgmont)"},{"issue":"3","key":"1021_CR65","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/070674371005500303","volume":"55","author":"M Sinyor","year":"2010","unstructured":"Sinyor M, Schaffer A, Levitt A. The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review. Can J Psychiatry. 2010;55(3):126\u201335. https:\/\/doi.org\/10.1177\/070674371005500303.","journal-title":"Can J Psychiatry."},{"issue":"Suppl 6","key":"1021_CR66","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4088\/JCP.8133su1c.03","volume":"70","author":"GI Papakostas","year":"2009","unstructured":"Papakostas GI. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry. 2009;70(Suppl 6):16\u201325. https:\/\/doi.org\/10.4088\/JCP.8133su1c.03.","journal-title":"J Clin Psychiatry."},{"issue":"1","key":"1021_CR67","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-244X-12-143","volume":"12","author":"M Garcia-Toro","year":"2012","unstructured":"Garcia-Toro M, Medina E, Galan JL, Gonzalez MA, Maurino J. Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment. BMC Psychiatry. 2012;12(1):143. https:\/\/doi.org\/10.1186\/1471-244X-12-143.","journal-title":"BMC Psychiatry"},{"issue":"17","key":"1021_CR68","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1002\/sim.1442","volume":"22","author":"PC Austin","year":"2003","unstructured":"Austin PC, Ghali WA, Tu JV. A comparison of several regression models for analysing cost of CABG surgery. Stat Med. 2003;22(17):2799\u2013815. https:\/\/doi.org\/10.1002\/sim.1442.","journal-title":"Stat Med"},{"issue":"4","key":"1021_CR69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","volume":"58","author":"S Schneeweiss","year":"2005","unstructured":"Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323\u201337. https:\/\/doi.org\/10.1016\/j.jclinepi.2004.10.012.","journal-title":"J Clin Epidemiol."}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-021-01021-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40273-021-01021-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-021-01021-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T12:57:53Z","timestamp":1622465873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40273-021-01021-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1007\/s40273-021-01021-w","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"16 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by Sage Therapeutics, Inc. and completed by Boston Strategic Partners (supported by Sage Therapeutics, Inc.).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Alix Arnaud and Ellison Suthoff are employees of Sage Therapeutics, Inc. with stock\/stock options.\u00a0Rita M. Tavares, Xuan Zhang and Aditi J. Ravindranath declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data that support the findings of this study are available from Truven Health Analytics MarketScan<sup>\u00ae<\/sup>, but restrictions apply to the availability of these data, which were used under license for the current study and so are not publicly available.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Custom code can be made available from authors upon reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability (software application or custom code)"}},{"value":"All authors contributed to the study conception and design. Analyses were performed by RMT, XZ, and AJR. The first draft of the manuscript was written by AJR, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}